Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Patient Fact Sheet: Rheumatoid Arthritis

From the College  |  Issue: November 2008  |  November 1, 2008

Rheumatoid arthritis (RA), the most common form of inflammatory arthritis, is a chronic disease that causes pain, stiffness, swelling, and limitation in the motion and function of multiple joints. RA is classified as an autoimmune disease, which develops because certain cells of the immune system malfunction and attack healthy joints.

More than one million Americans suffer from RA, and about 75% of those affected are women. The disease generally begins between the fourth and sixth decades of life; however, RA can develop at any age. Studies have shown that people who receive early treatment for RA feel better, are more likely to be able to lead an active life, and are less likely to experience the type of joint damage that leads to joint replacement. It is important for people with RA to remain physically active while occasionally scaling back activities when the disease flares.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Although the cause of RA remains unknown, exciting and rapidly advancing research reveals the factors that produce inflammation. Inflammatory chemicals released by the immune cells cause swelling and damage to cartilage and bone. According to patient–fact sheet writers Eric Ruderman, MD, and Siddharth Tambar, MD, “This research is giving us a better understanding of the immune and genetic factors that may be involved in the disease. As a result of this work, new medications have been developed that specifically block certain signals in the body from the immune system that are important in causing RA symptoms and joint damage.”

RA can be difficult to diagnose because it can begin gradually with subtle symptoms. There is no single test that confirms a diagnosis of RA. Rather, diagnosis is established by skillfully evaluating the appropriate symptoms, physical examination findings, laboratory tests, and X-rays.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Therapy for patients with RA has improved dramatically over the past 25 years. Current treatments offer most patients good to excellent relief of symptoms and the ability to continue to function at—or near—normal levels. Because there is no cure for RA, the goal of treatment is to minimize a patient’s symptoms and disability by introducing appropriate medical therapy early, before the joints are permanently damaged.

No single therapy is effective for all patients, and many patients will need to change treatment strategies during the course of their disease. Optimal treatment of RA often requires more than medication. Drs. Ruderman and Tambar agree that, “proper treatment requires comprehensive, coordinated care, patient education, and the expertise of a number of providers, including rheumatologists, primary-care physicians, and physical and occupational therapists.”

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsFrom the CollegeRheumatoid Arthritis Tagged with:Patient Fact SheetRARheumatoid arthritis

Related Articles

    Patient Fact Sheet: Juvenile Idiopathic Arthritis

    May 9, 2012

    Several types of arthritis fall under the JIA heading. This inflammation begins before patients reach the age of 16 years, and may involve one or many joints and cause other symptoms such as fevers, rash, and eye inflammation.

    Doest Rheumatoid Arthritis Take a Toll?

    November 15, 2013

    Exploring the Toll background

    T Cells in Systemic Lupus Erythematosus

    August 1, 2011

    Progress toward targeted therapy

    A Duet of Bone and the Immune System

    July 12, 2011

    Examining emerging perspectives in osteoimmunology

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences